The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Astilin 25 mg film-coated tablets



Ascot Laboratories (Ireland) LimitedPA23163/001/002

Main Information

Trade NameAstilin 25 mg film-coated tablets
Active SubstancesAMITRIPTYLINE HYDROCHLORIDE
Dosage FormFilm-coated tablet
Licence HolderAscot Laboratories (Ireland) Limited
Licence NumberPA23163/001/002

Group Information

ATC CodeN06AA Non-selective monoamine reuptake inhibitors
N06AA09 amitriptyline

Status

License statusAuthorised
Licence Issued01/11/2019
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportPDF Version
« Back